Atara Biotherapeutics (ATRA) Receivables (2020 - 2025)
Atara Biotherapeutics (ATRA) posted Receivables of $1.3 million for Q4 2025, down 34.5% on a QoQ basis from $1.9 million in Q3 2025, and down 15.45% year-over-year from $1.5 million in Q4 2024.
Atara Biotherapeutics (ATRA) Receivables (2020 - 2025) Analysis & Trends
Atara Biotherapeutics' Receivables history runs 6 years deep, the most recent figure standing at $1.3 million for Q4 2025.
- Quarterly Receivables fell 15.45% year-over-year to $1.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.3 million (down 15.45% YoY) and the FY2025 annual result came in at $1.3 million, down 15.45% from the prior year.
- Receivables was $1.3 million for Q4 2025 at Atara Biotherapeutics, down from $1.9 million in the prior quarter.
- Across five years, Receivables topped out at $40.2 million in Q4 2022 and bottomed at $163000.0 in Q3 2023.
- A 5-year average of $8.3 million and a median of $1.3 million in 2024 frame the typical range for Receivables.
- Peak annual rise in Receivables reached 8926.2% in 2024, while the deepest fall reached 95.65% in 2024.
- Atara Biotherapeutics' Receivables stood at $986000.0 in 2021, then soared by 3979.21% to $40.2 million in 2022, then fell by 15.2% to $34.1 million in 2023, then tumbled by 95.65% to $1.5 million in 2024, then decreased by 15.45% to $1.3 million in 2025.
- Business Quant data shows ATRA's Receivables at $1.3 million in Q4 2025, $1.9 million in Q3 2025, and $8.9 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 4.97 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 938.02 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 2.00 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 5.73 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 1.93 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Atara Biotherapeutics | 110.04 Mn | 101.68 Mn | 392,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.25 Mn |
| Sep 30, 2025 | 1.91 Mn |
| Mar 31, 2025 | 8.88 Mn |
| Dec 31, 2024 | 1.48 Mn |
| Sep 30, 2024 | 1.34 Mn |
| Jun 30, 2024 | 2.42 Mn |
| Mar 31, 2024 | 35.83 Mn |
| Dec 31, 2023 | 34.11 Mn |
| Sep 30, 2023 | 163,000.00 |
| Jun 30, 2023 | 507,000.00 |
| Mar 31, 2023 | 397,000.00 |
| Dec 31, 2022 | 40.22 Mn |
| Sep 30, 2022 | 249,000.00 |
| Jun 30, 2022 | 637,000.00 |
| Mar 31, 2022 | 668,000.00 |
| Dec 31, 2021 | 986,000.00 |
| Mar 31, 2021 | 9.61 Mn |
| Dec 31, 2020 | 1.25 Mn |